Mocetinostat combined with gemcitabine for the treatment of leiomyosarcoma: Preclinical correlates

Leiomyosarcoma (LMS) is a malignant soft tissue sarcoma (STS) with a dismal prognosis following metastatic disease. Chemotherapeutic intervention has demonstrated to have modest clinical efficacy with no curative potential in LMS patients. Previously, we demonstrated pan-HDAC inhibition to have a su...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:PLoS One
Autors principals: Lopez, Gonzalo, Braggio, Danielle, Zewdu, Abeba, Casadei, Lucia, Batte, Kara, Bid, Hemant Kumar, Koller, David, Yu, Peter, Iwenofu, Obiajulu Hans, Strohecker, Anne, Choy, Edwin, Lev, Dina, Pollock, Raphael
Format: Artigo
Idioma:Inglês
Publicat: Public Library of Science 2017
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5706733/
https://ncbi.nlm.nih.gov/pubmed/29186204
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0188859
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars